10 Healthy Pragmatic Free Trial Meta Habits: Difference between revisions

From Fanomos Wiki
Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that facilitates research on pragmatic trials. It is a platform that collects and shares clean trial data and ratings using PRECIS-2 allowing for multiple and diverse meta-epidemiological research studies to evaluate the effect of treatment on trials that employ different levels of pragmatism as well as other design features.<br><br>Background<br><br>Pragmatic trials provide evidence from the real world that can be used to make clinical decisions. However, the use of the term "pragmatic" is not uniform and its definition as well as assessment requires clarification. Pragmatic trials should be designed to inform policy and clinical practice decisions, rather than to prove the validity of a clinical or physiological hypothesis. A pragmatic trial should try to be as close as it is to actual clinical practices that include recruiting participants, setting up, delivery and implementation of interventions, determining and analysis results, as well as primary analysis. This is a significant difference between explanatory trials as defined by Schwartz &amp; Lellouch1 which are designed to prove a hypothesis in a more thorough way.<br><br>Truly pragmatic trials should not conceal participants or the clinicians. This can lead to a bias in the estimates of the effects of treatment. Practical trials should also aim to attract patients from a variety of health care settings, so that their results can be compared to the real world.<br><br>Furthermore, trials that are pragmatic must be focused on outcomes that matter to patients, such as the quality of life and functional recovery. This is particularly important in trials that involve surgical procedures that are invasive or have potential for dangerous adverse events. The CRASH trial29, for instance was focused on functional outcomes to compare a two-page report with an electronic system to monitor the health of hospitalized patients with chronic heart failure. Similarly, [https://www.inatega.com/modulos/midioma.php?idioma=pt&pag=https://pragmatickr.com/ 프라그마틱 슬롯체험] the catheter trial28 utilized symptomatic catheter-associated urinary tract infections as its primary outcome.<br><br>In addition to these characteristics pragmatic trials should reduce the trial procedures and data collection requirements to reduce costs. Finally pragmatic trials should strive to make their results as relevant to actual clinical practice as possible by making sure that their primary analysis follows the intention-to treat approach (as described in CONSORT extensions for pragmatic trials).<br><br>Despite these requirements however, a large number of RCTs with features that defy pragmatism have been incorrectly self-labeled pragmatic and published in journals of all types. This could lead to false claims about pragmatism, and the usage of the term should be standardized. The development of the PRECIS-2 tool, which provides a standard objective assessment of pragmatic features is a great first step.<br><br>Methods<br><br>In a pragmatic trial it is the intention to inform policy or clinical decisions by showing how an intervention could be integrated into everyday routine care. This is distinct from explanation trials that test hypotheses about the causal-effect relationship in idealized settings. In this way, pragmatic trials could have a lower internal validity than studies that explain and be more prone to biases in their design analysis, conduct, and design. Despite these limitations, pragmatic trials can be a valuable source of information for decisions in the context of healthcare.<br><br>The PRECIS-2 tool measures the level of pragmatism that is present in an RCT by assessing it across 9 domains, ranging from 1 (very explanatory) to 5 (very pragmatic). In this study the domains of recruitment, organisation and flexibility in delivery, flexible adherence and follow-up were awarded high scores. However, the principal outcome and the method for missing data were scored below the practical limit. This suggests that it is possible to design a trial with high-quality pragmatic features, without damaging the quality of its results.<br><br>However, it's difficult to determine the degree of pragmatism a trial is, since the pragmatism score is not a binary characteristic; certain aspects of a study can be more pragmatic than others. Moreover, protocol or logistic changes during a trial can change its score in pragmatism. In addition 36% of the 89 pragmatic trials discovered by Koppenaal and colleagues were placebo-controlled or conducted before licensing, and the majority were single-center. They are not close to the standard practice, and can only be considered pragmatic if their sponsors accept that these trials aren't blinded.<br><br>Another common aspect of pragmatic trials is that researchers attempt to make their findings more meaningful by analysing subgroups of the trial. This can lead to unbalanced analyses with lower statistical power. This increases the chance of omitting or ignoring differences in the primary outcomes. This was a problem during the meta-analysis of pragmatic trials due to the fact that secondary outcomes were not corrected for differences in covariates at the time of baseline.<br><br>In addition, pragmatic studies can present challenges in the collection and interpretation safety data. It is because adverse events tend to be self-reported and are susceptible to delays, errors or coding differences. It is crucial to increase the accuracy and quality of the results in these trials.<br><br>Results<br><br>Although the definition of pragmatism does not require that all trials are 100 percent pragmatic, there are benefits to including pragmatic components in clinical trials. These include:<br><br>Enhancing sensitivity to issues in the real world as well as reducing cost and size of the study and allowing the study results to be more quickly implemented into clinical practice (by including patients from routine care). However, pragmatic studies can also have disadvantages. The right amount of heterogeneity, for example could allow a study to expand its findings to different patients or settings. However, the wrong type can reduce the sensitivity of an assay and, consequently, decrease the ability of a study to detect small treatment effects.<br><br>A variety of studies have attempted to classify pragmatic trials using different definitions and scoring methods. Schwartz and Lellouch1 created a framework to discern between explanation-based studies that confirm a physiological hypothesis or clinical hypothesis,  [http://aklis.ru/bitrix/rk.php?goto=https://pragmatickr.com/ 프라그마틱 슬롯 환수율] 사이트 ([http://soheezzang.maru.net/bbs/skin/dasomlink_ver5_dot_banner/hit_plus.php?sitelink=https%3A%2F%2Fpragmatickr.com%2F&id=link&page=1&sn1=&divpage=1&sn=off&ss=on&sc=on&select_arrange=headnum&desc=asc&no=5 click the up coming document]) and pragmatic studies that help inform the choice for appropriate therapies in clinical practice. Their framework included nine domains that were scored on a scale of 1 to 5, with 1 indicating more lucid and 5 indicating more pragmatic. The domains included recruitment of intervention, setting up, delivery of intervention, flex adherence and primary analysis.<br><br>The original PRECIS tool3 was based on a similar scale and domains. Koppenaal et al10 devised an adaptation of this assessment dubbed the Pragmascope which was more user-friendly to use in systematic reviews. They found that pragmatic reviews scored higher across all domains, however they scored lower in the primary analysis domain.<br><br>This difference in primary analysis domains can be explained by the way most pragmatic trials analyze data. Certain explanatory trials however do not. The overall score was lower for pragmatic systematic reviews when the domains of the organization, flexibility of delivery and follow-up were combined.<br><br>It is important to remember that the term "pragmatic trial" does not necessarily mean a poor quality trial, and indeed there is a growing number of clinical trials (as defined by MEDLINE search, however it is neither sensitive nor specific) that employ the term 'pragmatic' in their title or abstract. The use of these terms in abstracts and titles could suggest a greater awareness of the importance of pragmatism, but it is unclear whether this is evident in the content of the articles.<br><br>Conclusions<br><br>As the importance of real-world evidence becomes increasingly widespread the pragmatic trial has gained momentum in research. They are randomized trials that compare real world care alternatives to experimental treatments in development. They are conducted with populations of patients more closely resembling those treated in regular care. This method can help overcome the limitations of observational research such as the biases that come with the reliance on volunteers, as well as the insufficient availability and coding variations in national registries.<br><br>Pragmatic trials have other advantages, including the ability to use existing data sources and a higher probability of detecting meaningful distinctions from traditional trials. However, pragmatic trials may have some limitations that limit their credibility and generalizability. Participation rates in some trials may be lower than expected due to the healthy-volunteering effect, financial incentives, or competition from other research studies. The need to recruit individuals in a timely manner also reduces the size of the sample and the impact of many pragmatic trials. In addition some pragmatic trials do not have controls to ensure that the observed differences are not due to biases in trial conduct.<br><br>The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described as pragmatism. They assessed pragmatism by using the PRECIS-2 tool, which includes the domains eligibility criteria as well as recruitment, flexibility in adherence to interventions and follow-up. They discovered that 14 of these trials scored highly or pragmatic pragmatic (i.e. scoring 5 or higher) in any one or more of these domains,  [http://www.pc-spec.info/common/pc/?u=https%3A%2F%2Fpragmatickr.com%2F 프라그마틱 환수율] and that the majority of these were single-center.<br><br>Trials with high pragmatism scores tend to have broader criteria for eligibility than traditional RCTs. They also have populations from various hospitals. The authors suggest that these traits can make pragmatic trials more effective and useful for daily practice, but they do not necessarily guarantee that a trial using a pragmatic approach is completely free of bias. Moreover, the pragmatism of the trial is not a fixed attribute; a pragmatic trial that doesn't contain all the characteristics of an explanatory trial may yield valuable and reliable results.
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that facilitates research on pragmatic trials. It shares clean trial data and ratings using PRECIS-2 permitting multiple and varied meta-epidemiological research studies to compare treatment effects estimates across trials that employ different levels of pragmatism as well as other design features.<br><br>Background<br><br>Pragmatic trials provide real-world evidence that can be used to make clinical decisions. However, the usage of the term "pragmatic" is not uniform and its definition and assessment requires further clarification. Pragmatic trials must be designed to inform policy and clinical practice decisions, rather than to prove an hypothesis that is based on a clinical or physiological basis. A pragmatic trial should aim to be as similar to actual clinical practice as possible, including in its selection of participants, setting and design, the delivery and implementation of the intervention, and the determination and analysis of outcomes and primary analysis. This is a significant difference between explanation-based trials, as described by Schwartz and Lellouch1 that are designed to prove a hypothesis in a more thorough way.<br><br>Truly pragmatic trials should not conceal participants or clinicians. This can lead to a bias in the estimates of treatment effects. The trials that are pragmatic should also try to attract patients from a variety of health care settings, to ensure that their findings can be applied to the real world.<br><br>Furthermore the focus of pragmatic trials should be on outcomes that are vital for patients, such as quality of life or functional recovery. This is especially important in trials that require the use of invasive procedures or could have harmful adverse effects. The CRASH trial29, for example was focused on functional outcomes to compare a two-page report with an electronic system to monitor the health of patients admitted to hospitals with chronic heart failure. In addition, the catheter trial28 used urinary tract infections caused by catheters as its primary outcome.<br><br>In addition to these features pragmatic trials should reduce trial procedures and data-collection requirements to cut costs and time commitments. Finaly these trials should strive to make their findings as relevant to real-world clinical practices as possible. This can be achieved by ensuring that their analysis is based on an intention-to treat method (as described within CONSORT extensions).<br><br>Despite these criteria however, a large number of RCTs with features that defy the notion of pragmatism were incorrectly labeled pragmatic and [https://www.medflyfish.com/index.php?action=profile;area=forumprofile;u=5383887 프라그마틱 무료] published in journals of all kinds. This can lead to false claims of pragmaticity and the use of the term must be standardized. The creation of a PRECIS-2 tool that offers a standardized objective evaluation of pragmatic aspects is a first step.<br><br>Methods<br><br>In a practical study it is the intention to inform clinical or policy decisions by demonstrating how an intervention can be integrated into routine care in real-world contexts. This differs from explanation trials that test hypotheses regarding the causal-effect relationship in idealized settings. Consequently, pragmatic trials may be less reliable than explanatory trials, and could be more susceptible to bias in their design, conduct, and analysis. Despite their limitations, pragmatic research can be a valuable source of data for making decisions within the healthcare context.<br><br>The PRECIS-2 tool assesses the level of pragmatism that is present in an RCT by assessing it across 9 domains that range from 1 (very explanatory) to 5 (very pragmatic). In this study, the recruit-ment, organisation, flexibility: delivery, flexible adherence and follow-up domains were awarded high scores, however, the primary outcome and the method for missing data were not at the pragmatic limit. This suggests that a trial can be designed with well-thought-out practical features, yet not damaging the quality.<br><br>It is hard to determine the degree of pragmatism that is present in a trial since pragmatism doesn't have a binary characteristic. Some aspects of a study can be more pragmatic than others. A trial's pragmatism could be affected by modifications to the protocol or logistics during the trial. Additionally 36% of the 89 pragmatic trials identified by Koppenaal and co. were placebo-controlled or conducted prior to licensing and most were single-center. They aren't in line with the norm and can only be referred to as pragmatic if their sponsors agree that such trials are not blinded.<br><br>A typical feature of pragmatic studies is that researchers attempt to make their findings more meaningful by studying subgroups of the trial sample. However, this often leads to unbalanced comparisons with a lower statistical power, increasing the chance of not or misinterpreting the results of the primary outcome. In the case of the pragmatic studies included in this meta-analysis, this was a major issue because the secondary outcomes were not adjusted for [https://www.google.pl/url?q=https://www.pdc.edu/?URL=https://sushigirl19.bravejournal.net/pragmatic-free-slots-strategies-from-the-top-in-the-industry 프라그마틱 무료 슬롯] 무료 ([https://images.google.bi/url?q=https://qooh.me/modemearth5 Read More On this page]) variations in baseline covariates.<br><br>In addition, pragmatic studies may pose challenges to gathering and interpretation of safety data. This is due to the fact that adverse events are typically self-reported and are susceptible to delays, errors or coding differences. It is important to increase the accuracy and quality of the results in these trials.<br><br>Results<br><br>Although the definition of pragmatism may not require that all clinical trials are 100% pragmatic There are advantages when incorporating pragmatic components into trials. These include:<br><br>Incorporating routine patients, the results of trials can be more quickly translated into clinical practice. However, pragmatic studies can also have drawbacks. The right kind of heterogeneity, like could allow a study to extend its findings to different settings or patients. However, the wrong type can decrease the sensitivity of the test and thus decrease the ability of a study to detect small treatment effects.<br><br>A variety of studies have attempted to classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and  [http://xojh.cn/home.php?mod=space&uid=1892317 프라그마틱 불법] Lellouch1 have developed a framework that can differentiate between explanation studies that confirm a physiological hypothesis or clinical hypothesis, and pragmatic studies that help inform the selection of appropriate treatments in clinical practice. Their framework comprised nine domains, each scoring on a scale ranging from 1 to 5 with 1 indicating more lucid and 5 indicating more practical. The domains included recruitment setting, setting, intervention delivery with flexibility, follow-up and primary analysis.<br><br>The initial PRECIS tool3 featured similar domains and scales from 1 to 5. Koppenaal and colleagues10 created an adaptation of this assessment, called the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic reviews scored higher on average in all domains, but scored lower in the primary analysis domain.<br><br>This distinction in the main analysis domain could be due to the fact that the majority of pragmatic trials analyze their data in the intention to treat manner, whereas some explanatory trials do not. The overall score for pragmatic systematic reviews was lower when the areas of management, flexible delivery and follow-up were merged.<br><br>It is crucial to keep in mind that a study that is pragmatic does not necessarily mean a low-quality study. In fact, there are a growing number of clinical trials which use the word 'pragmatic,' either in their abstracts or titles (as defined by MEDLINE, but that is neither precise nor sensitive). These terms may signal that there is a greater understanding of pragmatism in titles and abstracts, but it's unclear if this is reflected in content.<br><br>Conclusions<br><br>As the importance of real-world evidence grows commonplace the pragmatic trial has gained momentum in research. They are randomized trials that evaluate real-world care alternatives to clinical trials in development. They involve patient populations more closely resembling those treated in regular medical care. This method can help overcome the limitations of observational studies, such as the biases associated with reliance on volunteers and the lack of availability and coding variability in national registry systems.<br><br>Pragmatic trials have other advantages, like the ability to leverage existing data sources, and a greater probability of detecting meaningful differences from traditional trials. However, these trials could have some limitations that limit their reliability and generalizability. The participation rates in certain trials could be lower than expected due to the healthy-volunteering effect, financial incentives or competition from other research studies. Many pragmatic trials are also restricted by the need to recruit participants on time. Certain pragmatic trials lack controls to ensure that observed differences aren't due to biases in the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-labeled themselves as pragmatic and were published up to 2022. They evaluated pragmatism using the PRECIS-2 tool, which consists of the domains eligibility criteria as well as recruitment, flexibility in adherence to intervention, and follow-up. They found 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or higher) in at least one of these domains.<br><br>Trials that have a high pragmatism score tend to have more expansive eligibility criteria than traditional RCTs, which include very specific criteria that are unlikely to be present in the clinical setting, and comprise patients from a wide range of hospitals. The authors argue that these traits can make pragmatic trials more meaningful and applicable to everyday practice, but they do not necessarily guarantee that a trial conducted in a pragmatic manner is completely free of bias. Moreover, the pragmatism of trials is not a predetermined characteristic A pragmatic trial that does not possess all the characteristics of an explanatory trial can yield valuable and reliable results.

Latest revision as of 14:24, 20 January 2025

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that facilitates research on pragmatic trials. It shares clean trial data and ratings using PRECIS-2 permitting multiple and varied meta-epidemiological research studies to compare treatment effects estimates across trials that employ different levels of pragmatism as well as other design features.

Background

Pragmatic trials provide real-world evidence that can be used to make clinical decisions. However, the usage of the term "pragmatic" is not uniform and its definition and assessment requires further clarification. Pragmatic trials must be designed to inform policy and clinical practice decisions, rather than to prove an hypothesis that is based on a clinical or physiological basis. A pragmatic trial should aim to be as similar to actual clinical practice as possible, including in its selection of participants, setting and design, the delivery and implementation of the intervention, and the determination and analysis of outcomes and primary analysis. This is a significant difference between explanation-based trials, as described by Schwartz and Lellouch1 that are designed to prove a hypothesis in a more thorough way.

Truly pragmatic trials should not conceal participants or clinicians. This can lead to a bias in the estimates of treatment effects. The trials that are pragmatic should also try to attract patients from a variety of health care settings, to ensure that their findings can be applied to the real world.

Furthermore the focus of pragmatic trials should be on outcomes that are vital for patients, such as quality of life or functional recovery. This is especially important in trials that require the use of invasive procedures or could have harmful adverse effects. The CRASH trial29, for example was focused on functional outcomes to compare a two-page report with an electronic system to monitor the health of patients admitted to hospitals with chronic heart failure. In addition, the catheter trial28 used urinary tract infections caused by catheters as its primary outcome.

In addition to these features pragmatic trials should reduce trial procedures and data-collection requirements to cut costs and time commitments. Finaly these trials should strive to make their findings as relevant to real-world clinical practices as possible. This can be achieved by ensuring that their analysis is based on an intention-to treat method (as described within CONSORT extensions).

Despite these criteria however, a large number of RCTs with features that defy the notion of pragmatism were incorrectly labeled pragmatic and 프라그마틱 무료 published in journals of all kinds. This can lead to false claims of pragmaticity and the use of the term must be standardized. The creation of a PRECIS-2 tool that offers a standardized objective evaluation of pragmatic aspects is a first step.

Methods

In a practical study it is the intention to inform clinical or policy decisions by demonstrating how an intervention can be integrated into routine care in real-world contexts. This differs from explanation trials that test hypotheses regarding the causal-effect relationship in idealized settings. Consequently, pragmatic trials may be less reliable than explanatory trials, and could be more susceptible to bias in their design, conduct, and analysis. Despite their limitations, pragmatic research can be a valuable source of data for making decisions within the healthcare context.

The PRECIS-2 tool assesses the level of pragmatism that is present in an RCT by assessing it across 9 domains that range from 1 (very explanatory) to 5 (very pragmatic). In this study, the recruit-ment, organisation, flexibility: delivery, flexible adherence and follow-up domains were awarded high scores, however, the primary outcome and the method for missing data were not at the pragmatic limit. This suggests that a trial can be designed with well-thought-out practical features, yet not damaging the quality.

It is hard to determine the degree of pragmatism that is present in a trial since pragmatism doesn't have a binary characteristic. Some aspects of a study can be more pragmatic than others. A trial's pragmatism could be affected by modifications to the protocol or logistics during the trial. Additionally 36% of the 89 pragmatic trials identified by Koppenaal and co. were placebo-controlled or conducted prior to licensing and most were single-center. They aren't in line with the norm and can only be referred to as pragmatic if their sponsors agree that such trials are not blinded.

A typical feature of pragmatic studies is that researchers attempt to make their findings more meaningful by studying subgroups of the trial sample. However, this often leads to unbalanced comparisons with a lower statistical power, increasing the chance of not or misinterpreting the results of the primary outcome. In the case of the pragmatic studies included in this meta-analysis, this was a major issue because the secondary outcomes were not adjusted for 프라그마틱 무료 슬롯 무료 (Read More On this page) variations in baseline covariates.

In addition, pragmatic studies may pose challenges to gathering and interpretation of safety data. This is due to the fact that adverse events are typically self-reported and are susceptible to delays, errors or coding differences. It is important to increase the accuracy and quality of the results in these trials.

Results

Although the definition of pragmatism may not require that all clinical trials are 100% pragmatic There are advantages when incorporating pragmatic components into trials. These include:

Incorporating routine patients, the results of trials can be more quickly translated into clinical practice. However, pragmatic studies can also have drawbacks. The right kind of heterogeneity, like could allow a study to extend its findings to different settings or patients. However, the wrong type can decrease the sensitivity of the test and thus decrease the ability of a study to detect small treatment effects.

A variety of studies have attempted to classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and 프라그마틱 불법 Lellouch1 have developed a framework that can differentiate between explanation studies that confirm a physiological hypothesis or clinical hypothesis, and pragmatic studies that help inform the selection of appropriate treatments in clinical practice. Their framework comprised nine domains, each scoring on a scale ranging from 1 to 5 with 1 indicating more lucid and 5 indicating more practical. The domains included recruitment setting, setting, intervention delivery with flexibility, follow-up and primary analysis.

The initial PRECIS tool3 featured similar domains and scales from 1 to 5. Koppenaal and colleagues10 created an adaptation of this assessment, called the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic reviews scored higher on average in all domains, but scored lower in the primary analysis domain.

This distinction in the main analysis domain could be due to the fact that the majority of pragmatic trials analyze their data in the intention to treat manner, whereas some explanatory trials do not. The overall score for pragmatic systematic reviews was lower when the areas of management, flexible delivery and follow-up were merged.

It is crucial to keep in mind that a study that is pragmatic does not necessarily mean a low-quality study. In fact, there are a growing number of clinical trials which use the word 'pragmatic,' either in their abstracts or titles (as defined by MEDLINE, but that is neither precise nor sensitive). These terms may signal that there is a greater understanding of pragmatism in titles and abstracts, but it's unclear if this is reflected in content.

Conclusions

As the importance of real-world evidence grows commonplace the pragmatic trial has gained momentum in research. They are randomized trials that evaluate real-world care alternatives to clinical trials in development. They involve patient populations more closely resembling those treated in regular medical care. This method can help overcome the limitations of observational studies, such as the biases associated with reliance on volunteers and the lack of availability and coding variability in national registry systems.

Pragmatic trials have other advantages, like the ability to leverage existing data sources, and a greater probability of detecting meaningful differences from traditional trials. However, these trials could have some limitations that limit their reliability and generalizability. The participation rates in certain trials could be lower than expected due to the healthy-volunteering effect, financial incentives or competition from other research studies. Many pragmatic trials are also restricted by the need to recruit participants on time. Certain pragmatic trials lack controls to ensure that observed differences aren't due to biases in the trial.

The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-labeled themselves as pragmatic and were published up to 2022. They evaluated pragmatism using the PRECIS-2 tool, which consists of the domains eligibility criteria as well as recruitment, flexibility in adherence to intervention, and follow-up. They found 14 trials scored highly pragmatic or pragmatic (i.e. scoring 5 or higher) in at least one of these domains.

Trials that have a high pragmatism score tend to have more expansive eligibility criteria than traditional RCTs, which include very specific criteria that are unlikely to be present in the clinical setting, and comprise patients from a wide range of hospitals. The authors argue that these traits can make pragmatic trials more meaningful and applicable to everyday practice, but they do not necessarily guarantee that a trial conducted in a pragmatic manner is completely free of bias. Moreover, the pragmatism of trials is not a predetermined characteristic A pragmatic trial that does not possess all the characteristics of an explanatory trial can yield valuable and reliable results.